Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancer.

Bridges JF, la Cruz M, Pavilack M, Flood E, Janssen EM, Chehab N, Fernandes AW.

Future Oncol. 2019 Oct 17. doi: 10.2217/fon-2019-0396. [Epub ahead of print]

PMID:
31621403
2.

Screening-level risk assessment of methylmercury for non-anadromous Arctic char (Salvelinus alpinus).

Barst BD, Drevnick PE, Muir DCG, Gantner N, Power M, Köck G, Chéhab N, Swanson H, Rigét F, Basu N.

Environ Toxicol Chem. 2019 Mar;38(3):489-502. doi: 10.1002/etc.4341. Epub 2019 Feb 11.

PMID:
30561040
3.

Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody.

Yin Y, Ren X, Smith C, Guo Q, Malabunga M, Guernah I, Zhang Y, Shen J, Sun H, Chehab N, Loizos N, Ludwig DL, Ornitz DM.

Dis Model Mech. 2016 May 1;9(5):563-71. doi: 10.1242/dmm.024760. Epub 2016 Apr 7.

4.

Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase.

Cai Z, Chehab NH, Pavletich NP.

Mol Cell. 2009 Sep 24;35(6):818-29. doi: 10.1016/j.molcel.2009.09.007.

5.

The DNA damage checkpoint and human cancer.

Schultz LB, Chehab NH, Malikzay A, DiTullio RA Jr, Stavridi ES, Halazonetis TD.

Cold Spring Harb Symp Quant Biol. 2000;65:489-98. Review. No abstract available.

PMID:
12760066
6.

Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.

Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD, Berger SL.

Mol Cell. 2001 Dec;8(6):1243-54.

8.

p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks.

Schultz LB, Chehab NH, Malikzay A, Halazonetis TD.

J Cell Biol. 2000 Dec 25;151(7):1381-90.

9.

Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.

Satyamoorthy K, Chehab NH, Waterman MJ, Lien MC, El-Deiry WS, Herlyn M, Halazonetis TD.

Cell Growth Differ. 2000 Sep;11(9):467-74.

10.

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

Chehab NH, Malikzay A, Appel M, Halazonetis TD.

Genes Dev. 2000 Feb 1;14(3):278-88.

11.

Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13777-82.

12.

Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions.

Stavridi ES, Chehab NH, Caruso LC, Halazonetis TD.

Protein Sci. 1999 Sep;8(9):1773-9.

14.

CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.

Scolnick DM, Chehab NH, Stavridi ES, Lien MC, Caruso L, Moran E, Berger SL, Halazonetis TD.

Cancer Res. 1997 Sep 1;57(17):3693-6.

15.

[Tracheotomy scars. "Cross-over" platysma muscle flaps in the treatment of subcutaneous adhesions and depressions].

Reynaud JP, Bousquet P, Baron JL, Chehab N.

Ann Chir Plast Esthet. 1993 Aug;38(4):457-61. French.

PMID:
8074439

Supplemental Content

Loading ...
Support Center